374 related articles for article (PubMed ID: 22895266)
1. Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization.
Rao Q; Liu B; Cheng L; Zhu Y; Shi QL; Wu B; Jiang SJ; Wang Y; Wang X; Yu B; Zhang RS; Ma HH; Lu ZF; Tu P; Wang JD; Zhou XJ
Am J Surg Pathol; 2012 Sep; 36(9):1327-38. PubMed ID: 22895266
[TBL] [Abstract][Full Text] [Related]
2. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.
Inamura K; Fujiwara M; Togashi Y; Nomura K; Mukai H; Fujii Y; Yamamoto S; Yonese J; Fukui I; Ishikawa Y
Am J Surg Pathol; 2012 Jan; 36(1):35-42. PubMed ID: 22173116
[TBL] [Abstract][Full Text] [Related]
3. [Renal cell carcinoma with t(6;11)(p21.2;q13)/MALAT1-TFEB fusion: a clinical and pathological analysis].
Xia Q; Shi S; Shen Q; Wei X; Wang X; Ma H; Lu Z; Zhou X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):895-9. PubMed ID: 26888508
[TBL] [Abstract][Full Text] [Related]
4. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
[TBL] [Abstract][Full Text] [Related]
5. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
[TBL] [Abstract][Full Text] [Related]
6. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
7. Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.
Argani P; Yonescu R; Morsberger L; Morris K; Netto GJ; Smith N; Gonzalez N; Illei PB; Ladanyi M; Griffin CA
Am J Surg Pathol; 2012 Oct; 36(10):1516-26. PubMed ID: 22892601
[TBL] [Abstract][Full Text] [Related]
8. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
[TBL] [Abstract][Full Text] [Related]
9. Renal translocation carcinoma with expression of TFEB: presentation of a case with distinctive histological and immunohistochemical features.
Suárez-Vilela D; Izquierdo-García F; Méndez-Álvarez JR; Miguélez-García E; Domínguez-Iglesias F
Int J Surg Pathol; 2011 Aug; 19(4):506-9. PubMed ID: 19687027
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point.
Zhan HQ; Wang CF; Zhu XZ; Xu XL
J Clin Oncol; 2010 Dec; 28(34):e709-13. PubMed ID: 20823414
[No Abstract] [Full Text] [Related]
11. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.
Argani P; Laé M; Hutchinson B; Reuter VE; Collins MH; Perentesis J; Tomaszewski JE; Brooks JS; Acs G; Bridge JA; Vargas SO; Davis IJ; Fisher DE; Ladanyi M
Am J Surg Pathol; 2005 Feb; 29(2):230-40. PubMed ID: 15644781
[TBL] [Abstract][Full Text] [Related]
12. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
[TBL] [Abstract][Full Text] [Related]
13. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.
Xia QY; Wang XT; Fang R; Wang Z; Zhao M; Chen H; Chen N; Teng XD; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
Am J Surg Pathol; 2020 Apr; 44(4):477-489. PubMed ID: 31764220
[TBL] [Abstract][Full Text] [Related]
15. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
16. Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects.
Kuroda N; Tanaka A; Sasaki N; Ishihara A; Matsuura K; Moriyama M; Nagashima Y; Inoue K; Petersson F; Martignoni G; Michal M; Hes O
Histol Histopathol; 2013 Jun; 28(6):685-90. PubMed ID: 23426439
[TBL] [Abstract][Full Text] [Related]
17. TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity.
Argani P; Reuter VE; Zhang L; Sung YS; Ning Y; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Nov; 40(11):1484-1495. PubMed ID: 27565001
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
19. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.
Rao Q; Zhang XM; Tu P; Xia QY; Shen Q; Zhou XJ; Shi QL
Int J Clin Exp Pathol; 2013; 6(7):1452-7. PubMed ID: 23826432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
